Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation <i>In Vivo</i> and Human Bladder Cancer Invasion <i>In Vitro</i> by Targeting STAT1/FOXO1 AxisGuosong Jiang, Amy D. Wu, Chao Huang et al.|Cancer Prevention Research|2016Cited by 68
Supplemental Figure 1 from Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation <i>In Vivo</i> and Human Bladder Cancer Invasion <i>In Vitro</i> by Targeting STAT1/FOXO1 AxisGuosong Jiang, Chuanshu Huang, Xin Liao et al.|Unknown|2023Cited by 0
Supplemental Figure 2 from Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation <i>In Vivo</i> and Human Bladder Cancer Invasion <i>In Vitro</i> by Targeting STAT1/FOXO1 AxisGuosong Jiang, Chuanshu Huang, Amy D. Wu et al.|Unknown|2023Cited by 0
Supplemental Figure 3 from Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation <i>In Vivo</i> and Human Bladder Cancer Invasion <i>In Vitro</i> by Targeting STAT1/FOXO1 AxisGuosong Jiang, Chuanshu Huang, Amy D. Wu et al.|Unknown|2023Cited by 0
Supplemental Figure 2 from Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation <i>In Vivo</i> and Human Bladder Cancer Invasion <i>In Vitro</i> by Targeting STAT1/FOXO1 AxisGuosong Jiang, Chuanshu Huang, Amy D. Wu et al.|Unknown|2023Cited by 0